Doctot

An abbreviation of DOCtor's Tools Of Trade (whilst simultaneously being a portmanteau of "Doctor" and "Robot"), Doctot is an academically motivated Health Informatics Consortium dedicated to the promotion of Best Practice. Primarily focused upon the development of the App Store's original and best Clinical Diagnosis App range; Doctot's validated, fast-acting and user-friendly offerings help to satisfy the needs of not only Health Care Professionals, but Health Interest Groups, Governmental Bodies, 3rd Level Institutions and Pharmaceutical Companies from around the globe. Enabling Medical Practitioners to make safer diagnoses, provide greater treatment strategies, and save critical time; Doctot's ever-evolving portfolio of award-winning Clinical Diagnosis Aids range in discipline from Neurology to Cardiology. Working in conjunction with Healthcare giants such as the World Health Organisation, the Global Initiative for Chronic Obstructive Lung Disease, and the Royal College of Physicians; elegantly crafted native Apps, which pre-existing paper-format tools cannot match for accuracy, efficiency or usability, are made available for download. Among the Independent publisher's market-leading product catalogue is the exclusively licensed GOLD COPD Strategy App, which provides physicians with the Gold Standard clinical tool for treating Chronic Obstructive Pulmonary Disease. Continuously evolving as a Consortium, Doctot have also successfully entered both the Drug Utilisation App and Medical Conference Information App sectors, listing Sanofi and the Irish Gerontological Society among their clients within these exciting breakthrough areas.

• Employees 10
• Founded 2009
• Annual Revenue $10000000